Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additional Dose of Viral Vector and mRNA COVID-19 Vaccines in Kidney Transplant Recipients
TCTR20211102003Phase 3Completed
- Sponsor
- National Research Council of Thailand
- Start
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of mRNA COVID-19 vaccine in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Nov 2021; status: completed.
02
Drugs
mRNA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211102003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211102003.